Related Experiment Video
Updated: Jul 27, 2026
07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Transcatheter PFO closure with a prominent Eustachian valve
D Skowasch1, M Peuster, R Andrié
1Department of Cardiology, Heart Center University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.
Zeitschrift Fur Kardiologie
|February 14, 2004
Summary
A 57-year-old woman underwent successful patent foramen ovale (PFO) closure. A Helex Septal Occluder was used due to complex atrial anatomy and a prominent Eustachian valve, ensuring safe device implantation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Device Technology
Background:
- Patent Foramen Ovale (PFO) closure is a common interventional cardiology procedure.
- Complex atrial anatomy presents challenges for device implantation and patient outcomes.
- Prominent Eustachian valves can interfere with standard occluder device placement.
Observation:
- A 57-year-old female patient presented with a PFO requiring closure.
- The patient exhibited complex atrial anatomy.
- A prominent Eustachian valve was noted, posing a potential risk to device deployment.
Findings:
- Successful PFO closure was achieved using a Helex Septal Occluder.
- The Helex device was chosen specifically to mitigate risks associated with the prominent Eustachian valve.
- The implantation procedure was technically successful without immediate complications.
Implications:
- This case highlights the successful use of the Helex Septal Occluder in a challenging anatomical scenario.
- It demonstrates the importance of selecting appropriate devices based on individual patient anatomy for PFO closure.
- The findings contribute to the understanding of device selection and procedural success in complex PFO cases.
Related Concept Videos
01:23Oxygen Delivering System III: Tracheostomy and T-piece
Oxygen delivery is critical in clinical care, especially for patients with respiratory disorders or those undergoing surgical procedures. Various systems, such as tracheostomy and the T-piece, deliver oxygen to the lungs, ensuring adequate arterial oxygenation.
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...